By-health Co., Ltd. (300146.SZ)
CNY 12.76
(-0.39%)
CNY 12.76
(-0.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.4 Billion | 7.86 Billion | 7.43 Billion | 6.09 Billion | 5.26 Billion | 4.35 Billion |
| Cost of Revenue | 2.93 Billion | 2.49 Billion | 2.52 Billion | 2.26 Billion | 1.8 Billion | 1.4 Billion |
| Gross Profit | 6.46 Billion | 5.36 Billion | 4.9 Billion | 3.82 Billion | 3.46 Billion | 2.94 Billion |
| Operating Expenses | 4.41 Billion | 3.77 Billion | 3.05 Billion | 2.45 Billion | 2.2 Billion | 1.75 Billion |
| Selling, General and Administrative Expenses | 4.2 Billion | 3.23 Billion | 2.55 Billion | 1.92 Billion | 1.76 Billion | 1.4 Billion |
| Research and Development Expenses | 169.37 Million | 158.49 Million | 150.29 Million | 139.95 Million | 126.04 Million | 103.48 Million |
| Other Expenses | 775.42 Thousand | 374.01 Million | 346.36 Million | 386.43 Million | 320.07 Million | 26.38 Million |
| Cost and Expenses | 7.33 Billion | 6.26 Billion | 5.57 Billion | 4.72 Billion | 4 Billion | 3.16 Billion |
| Operating Income | 2.06 Billion | 1.6 Billion | 2.02 Billion | 1.78 Billion | 1.34 Billion | 1.1 Billion |
| Interest Expense | 4.71 Million | 2.2 Million | 10.18 Million | 23.73 Million | 44.49 Million | 17.58 Million |
| Income Tax Expense | 417.17 Million | 293.52 Million | 411.69 Million | 224.58 Million | -9.82 Million | 220.55 Million |
| Earnings before Tax | 2.23 Billion | 1.7 Billion | 2.17 Billion | 1.76 Billion | -424.86 Million | 1.12 Billion |
| Net Income | 1.74 Billion | 1.38 Billion | 1.75 Billion | 1.52 Billion | -415.04 Million | 1 Billion |
| Earnings Per Share Basic | 1.03 | 0.82 | 1.03 | 0.96 | -0.28 | 0.69 |
| Earnings Per Share Diluted | 1.03 | 0.82 | 1.03 | 0.96 | -0.28 | 0.69 |
| Weighted Average Shares Outstanding | 1.69 Billion | 1.7 Billion | 1.7 Billion | 1.58 Billion | 1.48 Billion | 1.45 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.69 Billion | 1.7 Billion | 1.7 Billion | 1.58 Billion | 1.48 Billion | 1.45 Billion |
| Gross Margin | 0.69 | 0.68 | 0.66 | 0.63 | 0.66 | 0.68 |
| EBIT Margin | 0.26 | 0.28 | 0.32 | 0.29 | 0.30 | 0.33 |
| Profit Margin | 0.19 | 0.18 | 0.24 | 0.25 | -0.08 | 0.23 |
| EBITDA | 2.48 Billion | 1.95 Billion | 2.41 Billion | 2 Billion | -120.39 Million | 1.3 Billion |
| Earnings Before Tax Margin | 0.22 | 0.20 | 0.27 | 0.29 | 0.26 | 0.25 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.12 Billion | 1.94 Billion | 2.63 Billion | 9.31 Billion | 1.6 Billion | 2.18 Billion |
| Cost of Revenue | 388.6 Million | 692.55 Million | 796.4 Million | 3.08 Billion | 605.16 Million | 700.65 Million |
| Gross Profit | 731.71 Million | 1.25 Billion | 1.83 Billion | 6.23 Billion | 998.33 Million | 1.48 Billion |
| Operating Expenses | 810.38 Million | 1.13 Billion | 998.48 Million | 4.37 Billion | 1.26 Billion | 1.1 Billion |
| Selling, General and Administrative Expenses | 1.22 Billion | 1.08 Billion | 963.93 Million | - | 1.21 Billion | 1.2 Billion |
| Research and Development Expenses | 46.54 Million | 36.17 Million | 31.4 Million | - | 53.47 Million | 42.75 Million |
| Other Expenses | -459.23 Million | -5.27 Million | -3.14 Million | 775.42 Thousand | -3.68 Million | 10.66 Million |
| Cost and Expenses | 1.19 Billion | 1.82 Billion | 1.79 Billion | 7.45 Billion | 1.87 Billion | 1.8 Billion |
| Operating Income | -57.18 Million | 124.04 Million | 839.42 Million | 1.85 Billion | -270.3 Million | 415.03 Million |
| Interest Expense | 7.19 Million | 1.79 Million | 1.86 Million | 4.71 Million | 2.07 Million | 1.79 Million |
| Income Tax Expense | -28.54 Million | 39.26 Million | 177.27 Million | 417.17 Million | -25.15 Million | 62.54 Million |
| Earnings before Tax | -46.52 Million | 200.44 Million | 896.23 Million | 2.23 Billion | -175.93 Million | 425.7 Million |
| Net Income | -22.41 Million | 164.47 Million | 726.55 Million | 1.74 Billion | -154.79 Million | 355.7 Million |
| Earnings Per Share Basic | -0.01 | 0.10 | 0.43 | - | -0.09 | 0.21 |
| Earnings Per Share Diluted | -0.01 | 0.10 | 0.43 | - | -0.09 | 0.21 |
| Weighted Average Shares Outstanding | 1.68 Billion | 1.7 Billion | 1.7 Billion | 1.7 Billion | 1.7 Billion | 1.7 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.68 Billion | 1.7 Billion | 1.7 Billion | 1.7 Billion | 1.7 Billion | 1.7 Billion |
| Gross Margin | 0.65 | 0.64 | 0.70 | 0.67 | 0.62 | 0.68 |
| EBIT Margin | -0.04 | 0.10 | 0.35 | - | -0.13 | 0.20 |
| Profit Margin | -0.02 | 0.08 | 0.28 | 0.19 | -0.10 | 0.16 |
| EBITDA | -39.32 Million | 187.27 Million | 911.46 Million | - | -209.07 Million | 433 Million |
| Earnings Before Tax Margin | -0.05 | 0.06 | 0.32 | 0.20 | -0.17 | 0.19 |
002050
CDG
300840
600052
3658
CRBU